Sanofi Genzyme: Medical Device Recalls in 2018

Updated on March 25, 2026.

According to to data from the FDA, there was 1 medical device recall made by Sanofi Genzyme in 2018. See the detail of the recall below.

You can see similar recalls for other firms.

Data Source: FDA.

See this for other years:

Synvisc-One ¿ (hylan G-F 20), 6mL delivered from a 10mL syringe Product Usage: A elastoviscous high molecular weight fluid containing hylan A and hylan B polymers produced from chicken combs. Synvisc-One is administered as a single intra-articular injection. Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.